Impli Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $126K

  • Investors
  • 16

Impli General Information

Description

Developer of a monitoring device designed to continuously track hormone levels in patients undergoing fertility treatments. The company's device monitors hormone levels directly from subcutaneous tissue to make informed treatment decisions, enabling healthcare providers to implement preventive measures before complications arise.

Contact Information

Website
www.impli.org
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Scale Space
  • 58 Wood Lane
  • London W12 7RZ
  • England, United Kingdom
+44 020
Primary Industry
Monitoring Equipment
Other Industries
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, FemTech, HealthTech
Corporate Office
  • Scale Space
  • 58 Wood Lane
  • London W12 7RZ
  • England, United Kingdom
+44 020

Impli Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Impli Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 15-Jan-2026 $126K Completed Generating Revenue
11. Accelerator/Incubator 01-Sep-2025 Completed Generating Revenue
10. Later Stage VC 28-May-2025 Completed Generating Revenue
9. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
8. Accelerator/Incubator 05-Dec-2024 Completed Generating Revenue
7. Accelerator/Incubator 18-Nov-2024 Completed Generating Revenue
6. Accelerator/Incubator 13-Dec-2023 Completed Generating Revenue
5. Early Stage VC Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
To view Impli’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Impli Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a monitoring device designed to continuously track hormone levels in patients undergoing fertility treatmen
Monitoring Equipment
London, United Kingdom
8 As of 2025

Emeryville, CA
 

Berlin, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Impli Competitors (3)

One of Impli’s 3 competitors is Profusa, a Formerly VC-backed company based in Emeryville, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Profusa Formerly VC-backed Emeryville, CA
Inne Venture Capital-Backed Berlin, Germany
Ovia Health Venture Capital-Backed Westborough, MA
You’re viewing 3 of 3 competitors. Get the full list »

Impli Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Impli Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024313302-A1 Implantable apparatuses, biosensor devices, systems and methods Pending 19-Jun-2023
EP-4481386-A1 Implantable apparatuses, biosensor devices, systems and methods Pending 19-Jun-2023
EP-4728276-A1 Implantable apparatuses, biosensor devices, systems and methods Pending 19-Jun-2023
WO-2024260960-A1 Implantable apparatuses, biosensor devices, systems and methods Inactive 19-Jun-2023 G01N33/54353

Impli Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Impli Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fondation pour l'Innovation Technologique Government
Grow London Accelerator/Incubator
Deuce Capital Venture Capital Minority
Fern Capital Group Venture Capital Minority
Biopole (Epalinges) Accelerator/Incubator
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial

Impli FAQs

  • When was Impli founded?

    Impli was founded in 2019.

  • Where is Impli headquartered?

    Impli is headquartered in London, United Kingdom.

  • What is the size of Impli?

    Impli has 8 total employees.

  • What industry is Impli in?

    Impli’s primary industry is Monitoring Equipment.

  • Is Impli a private or public company?

    Impli is a Private company.

  • What is Impli’s current revenue?

    The current revenue for Impli is .

  • How much funding has Impli raised over time?

    Impli has raised $1.63M.

  • Who are Impli’s investors?

    Fondation pour l'Innovation Technologique, Grow London, Deuce Capital, Fern Capital Group, and Biopole (Epalinges) are 5 of 16 investors who have invested in Impli.

  • Who are Impli’s competitors?

    Profusa, Inne, and Ovia Health are competitors of Impli.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process